Irisin Hormone Levels in Endometrial Hyperplasia

Status Recruiting

Clinical Trial Summary

The purpose of the study is to determine serum irisin hormone levels an its relation between endometrial hyperplasia

Clinical Trial Description

The study consisted of two groups. The first group was formed of the patients diagnosed endometrial hyperplasia histopathologically , and the controls were healthy women admitted to the clinic just for annual examination without any complain and symptoms. Patients in the 35-50 age range in both groups were included in the study. The histopathologic diagnosis of patients was established for Kayseri Education and Research Hospital Pathology clinics. Demographic parameters such as age, menopausal status, body mass index (BMI), body weight and known familial cancer story were registered.

Pregnancy, liver function disorders, cardiovascular disease, metabolic disease, diabetes, chronic kidney disease, central nerves system disease, immunosuppressive drug use, another known malignancy and excessive exercises in among one month were all exclusion criteria for the patients.

3 cc peripheral venous blood samples were taken in the patients' diagnosed endometrial hyperplasia in the course of evaluation the biopsy results and in controls during their examinations just for only once. Blood samples were centrifuged in 3200 rpm speed for 10 minutes, and stored in -80 'C until the analysis. Blood samples were evaluated on the same day after four mounts for stored first blood sample. Serum Irisin levels were evaluated with enzyme- linked immunosorbent assays kit (Catalog number: K4761-100 Biovision USA) in Kayseri Research and Education Hospital Biochemical Clinics. ;

Study Design

Observational Model: Case Control, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02903797
Study type	Observational
Source	Kayseri Education and Research Hospital
Contact	Erdem SAHIN, Principal Investigator
Phone	+905321688683
Email	erdemsahin07@hotmail.com
Status	Recruiting
Phase	N/A
Start date	August 2016
Completion date	February 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05378152` - Assessing the Benefit of Pipelle Biopsy in Patients With Postmenopausal Bleeding and an Atrophic-appearing Cavity	N/A
Withdrawn	`NCT00123175` - Treatment of Endometrial Hyperplasia With an Intrauterine Device (IUD)	Phase 1/Phase 2
Completed	`NCT02100137` - Women With Asymptomatic Endometrial Hyperplasia	N/A
Completed	`NCT00242710` - Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women	Phase 3
Not yet recruiting	`NCT04191603` - TWO DİFFERENT ELECTROSURGERY DEVICES AS MONOPOLAR HOOC AND PLASMAKINETIC BIPOLAR SPATULA EFFECTIVENESS DURING COLPOTOMY	N/A
Completed	`NCT03032848` - Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients	Phase 4
Completed	`NCT00339651` - Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer
Recruiting	`NCT01234818` - Management of Endometrial Hyperplasia With a LNG-IUS: Multicenter Study: KGOG2006	Phase 2
Recruiting	`NCT04362046` - Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia	N/A
Active, not recruiting	`NCT05257057` - Frequency of Endometrial Cancer Precursors Associated With Lynch Syndrome
Completed	`NCT00883662` - Mirena Observational Program	N/A
Completed	`NCT01499602` - Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women	N/A
Completed	`NCT01074892` - A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia	Phase 4
Not yet recruiting	`NCT05903131` - A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia	Phase 2
Not yet recruiting	`NCT05829460` - Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia	Phase 2
Withdrawn	`NCT04897217` - Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia	Phase 3
Recruiting	`NCT03176992` - Surgicel® & Endometrial Ablation in the Management of Perimenpausal Heavy Menstrual Bleeding	Phase 2
Not yet recruiting	`NCT00919919` - Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen	Phase 2
Recruiting	`NCT03207126` - Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy?	N/A
Recruiting	`NCT03207061` - Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer?	N/A